AzTrials
AzTrials

SuicideSPARCNCT04893447

Suicide Prevention Among Recipients of Care

A study testing SPI+ and SP+CC (Caring Contacts) in people with Suicide and Suicide, Attempted, run by St. Luke's Health System, Boise, Idaho at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record

Search all trials

Trial summary

Randomized controlled trial to determine the best brief suicide prevention intervention for adults and adolescents who screen positive for suicidal ideation or behavior in emergency departments or primary care clinics. Read more about this study

Who is it for?
Ages 12 years and older
Conditions the study is for
Suicide, Suicide, Attempted, Suicidal Ideation
What is being tested?
SPI+ and SP+CC (Caring Contacts)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
1,520 participants
Where
1 siteUnited States
Study dates
20 May 2021to 7 Jul 2024
Phase
Interventional

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 12 years and older
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • Patient at St. Luke's Health System Emergency Department or Primary Care Clinic
  • 12-17 years old (adolescents) or 18+ years old (adults)
  • Screened positive for suicide risk on C-SSRS (any response of "yes") during current visit, or current visit is related to a suicide attempt
  • Access to a phone for the duration of the study with the ability to receive calls
  • The ability to send and receive email messages (required) and text messages (optional)
  • English or Spanish speaking and reading

Who cannot join

  • Unable or unwilling to provide informed consent to participate
  • Inappropriate for study participation based on the clinical judgment of provider

Trial locations and contacts

1 site in 1 country.

United States1 site
  • St. Luke's Health System

    Boise, Idaho, 83712

Other trials in United States

About this study

Official title: Comparing the Effectiveness of Safety Planning Plus Follow-Up From a Suicide Prevention Hotline (SPI+) vs Safety Planning Plus Caring Contacts (SP+CC) Among Adults and Adolescents at Risk for Suicide in Primary Care or Emergency Departments

Randomized controlled trial to determine the best brief suicide prevention intervention for adults and adolescents who screen positive for suicidal ideation or behavior in emergency departments or primary care clinics.

Aim 1: Compare the effectiveness of two brief suicide prevention interventions (safety planning intervention plus structured phone-based follow-up from a suicide prevention hotline (SPI+), versus safety planning intervention plus caring contacts (CC)) to (a) reduce suicidal ideation and behavior, (b) reduce loneliness, (c) reduce return to care for suicidality, and (d) increase uptake of outpatient mental healthcare services over 12 months among adult and adolescent patients screening positive for suicide in emergency departments (EDs) and primary care clinics.

Read more

Aim 2: Assess the acceptability of connection and support planning and the safety planning intervention, with or without follow-up among providers and clinical staff in EDs and primary care clinics.

Aim 3: Assess the acceptability of SPI+ and SP+CC among adult and adolescent patients.

Being tested
SPI+, SP+CC (Caring Contacts)
Keywords
Brief Interventions, Caring Contacts, Care Transitions, Follow-up, Emergency Department, Primary Care, Safety Planning Intervention, Safety Plan, Suicide, Suicide Prevention, Adult, Adolescent, Brief Contact Intervention
Medical subject headings
Suicide, Suicide, Attempted, Suicidal Ideation, Psychological Well-Being, Mental Disorders, Emergencies, Depressive Disorder, Depression

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • SPI+Behavioural

    Also called phone-based follow-up, brief contact intervention

    Suicide prevention hotline follow-up specialists will call participants to (1) conduct a brief suicide risk assessment; (2) review and discuss the participant's connection and support plan or safety plan; and (3) provide referrals to social services or other support with treatment engagement, if indicated. Participants will receive at least one and optional additional phone calls, generally delivered according to the following schedule: days 3, 7, 14, 30, 60, 90. Modifications may be made to the schedule due to weekends, holidays, or participant availability, and additional calls may be scheduled as desired by the participant. The follow-up will stop once the participant is successfully engaged in outpatient treatment or does not desire further follow-up support.

  • SP+CC (Caring Contacts)Behavioural

    Also called Brief contact intervention, text-based follow-up, email follow-up

    SP+CC follow-up includes one phone conversation with a suicide prevention hotline follow-up specialist and a series of personalized caring messages sent over the course of 12 months via text or email (based on participant preference). Caring contacts will generally be sent according to the following schedule: 3 in the first week, 6 weekly, 6 bi-weekly, 4 monthly; 2 bi-monthly, and one each for the participant's birthday, Thanksgiving, Christmas, and New Year's (total of 25 over 12 months). Slight variation in the schedule is allowed. There is no expectation that participants respond to the text messages; if they do, follow-up specialists reply to any incoming texts. Replies are individually-tailored and caring.

Study groups in NCT04893447
Study groupRoleWhat they receive
SPI+: Safety Planning Intervention plus structured phone-based follow-upExperimentalThe Safety Planning Intervention (SPI+) includes safety planning (moderate or high risk for suicide) or connection \& support planning (low risk for suicide) at the clinic or ED, plus a structured telephone-based intervention from a suicide prevention hotline
Receives: Behavioral: SPI+
Caring Contacts: Safety Planning Intervention plus Caring Contacts (SP+CC)ExperimentalSP+CC will include safety planning (moderate or high risk for suicide) or connection \& support planning (low risk for suicide) at the clinic or ED, plus caring text messages or emails from a suicide prevention hotline.
Receives: Behavioral: SP+CC (Caring Contacts)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Suicidal Ideation & Behavior; measured using the Columbia Suicide Severity Rating Scale (C-SSRS) since-last-contact screener (self-assessment)

    6-item questionnaire with yes/no response options. Scores range from 0 (no risk) to 6 (high risk)

    Measured: 6 months

Secondary outcomes (7)
  1. Loneliness; measured using the NIH Toolbox Emotion Batteries Loneliness Scale

    5-item questionnaire with Likert scale response options (1=never, 5=always). Scores range from 5 (no loneliness) to 25 (high levels of loneliness).

    Measured: 6 months

  2. Loneliness; measured using the NIH Toolbox Emotion Batteries Loneliness Scale

    5-item questionnaire with Likert scale response options (1=never, 5=always). Scores range from 5 (no loneliness) to 25 (high levels of loneliness).

    Measured: 12 months

  3. Utilization of Emergency Department for Suicidality

    Measured through self-report

    Measured: 6 months

  4. Utilization of Emergency Department for Suicidality

    Measured through self-report

    Measured: 12 months

  5. Attendance at Outpatient Behavioral Health Appointments

    Measured through self-report

    Measured: 6 months

  6. Attendance at Outpatient Behavioral Health Appointments

    Measured through self-report

    Measured: 12 months

  7. Suicidal Ideation & Behavior; measured using the Columbia Suicide Severity Rating Scale (C-SSRS) since-last-contact screener (self-assessment)

    6-item questionnaire with yes/no response options. Scores range from 0 (no risk) to 6 (high risk)

    Measured: 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 May 2021
  2. Study start20 May 2021
  3. Primary completion7 Jul 2024
  4. Study completion7 Jul 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Model description
Individual-level randomization to one of two treatment arms
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
1,520 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04893447
Sponsor's protocol ID
2019-0026
Acronym
SPARC
Status last verified
Nov 2024
First submitted
28 Apr 2021
Last updated
12 Nov 2024
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: After publication of the final research report, de-identified data may be shared with other researchers.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in